260 related articles for article (PubMed ID: 20547213)
21. Temporal changes of astrocyte activation and glutamate transporter-1 expression in the spinal cord after spinal nerve ligation-induced neuropathic pain.
Wang W; Wang W; Wang Y; Huang J; Wu S; Li YQ
Anat Rec (Hoboken); 2008 May; 291(5):513-8. PubMed ID: 18384122
[TBL] [Abstract][Full Text] [Related]
22. The Glt1 glutamate receptor mediates the establishment and perpetuation of chronic visceral pain in an animal model of stress-induced bladder hyperalgesia.
Ackerman AL; Jellison FC; Lee UJ; Bradesi S; Rodríguez LV
Am J Physiol Renal Physiol; 2016 Apr; 310(7):F628-F636. PubMed ID: 26697981
[TBL] [Abstract][Full Text] [Related]
23. Changes in the glutamate biomarker expression in rats vulnerable or resistant to the rewarding effects of cocaine and their reversal by ceftriaxone.
Niedzielska-Andres E; Mizera J; Sadakierska-Chudy A; Pomierny-Chamioło L; Filip M
Behav Brain Res; 2019 Sep; 370():111945. PubMed ID: 31100299
[TBL] [Abstract][Full Text] [Related]
24. Loss of the glutamate transporter splice-variant GLT-1b in inferior colliculus and its prevention by ceftriaxone in thiamine deficiency.
Jhala SS; Wang D; Hazell AS
Neurochem Int; 2011 Apr; 58(5):558-63. PubMed ID: 21256174
[TBL] [Abstract][Full Text] [Related]
25. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
26. Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice.
Fan S; Xian X; Li L; Yao X; Hu Y; Zhang M; Li W
J Alzheimers Dis; 2018; 66(4):1731-1743. PubMed ID: 30452416
[TBL] [Abstract][Full Text] [Related]
27. Hydrogen enriched saline alleviates morphine tolerance via inhibiting neuroinflammation, GLT-1, GS nitration and NMDA receptor trafficking and functioning in the spinal cord of rats.
Li Q; Zhang H; Jia Z; Zhang L; Li Y; Xu R; Wang C; Yu Y
Neurosci Lett; 2021 Jun; 755():135847. PubMed ID: 33774150
[TBL] [Abstract][Full Text] [Related]
28. Astrocytic c-Jun N-terminal kinase-histone deacetylase-2 cascade contributes to glutamate transporter-1 decrease and mechanical allodynia following peripheral nerve injury in rats.
Lu R; Cui SS; Wang XX; Chen L; Liu F; Gao J; Wang W
Brain Res Bull; 2021 Oct; 175():213-223. PubMed ID: 34333051
[TBL] [Abstract][Full Text] [Related]
29. Ceftriaxone regulates glutamate production and vesicular assembly in presynaptic terminals through GLT-1 in APP/PS1 mice.
Fan S; Li L; Xian X; Liu L; Gao J; Li W
Neurobiol Learn Mem; 2021 Sep; 183():107480. PubMed ID: 34153453
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of spinal glutamate transporters contributes to anti-hypersensitive effects of valproate in rats after peripheral nerve injury.
Hobo S; Eisenach JC; Hayashida K
Neurosci Lett; 2011 Sep; 502(1):52-5. PubMed ID: 21802494
[TBL] [Abstract][Full Text] [Related]
31. Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats.
Alhaddad H; Das SC; Sari Y
Psychopharmacology (Berl); 2014 Oct; 231(20):4049-57. PubMed ID: 24687412
[TBL] [Abstract][Full Text] [Related]
32. Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression.
LaCrosse AL; O'Donovan SM; Sepulveda-Orengo MT; McCullumsmith RE; Reissner KJ; Schwendt M; Knackstedt LA
J Neurosci; 2017 Jun; 37(24):5809-5821. PubMed ID: 28495973
[TBL] [Abstract][Full Text] [Related]
33. Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression.
LaCrosse AL; Hill K; Knackstedt LA
Eur Neuropsychopharmacol; 2016 Feb; 26(2):186-194. PubMed ID: 26706696
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation.
Chu K; Lee ST; Sinn DI; Ko SY; Kim EH; Kim JM; Kim SJ; Park DK; Jung KH; Song EC; Lee SK; Kim M; Roh JK
Stroke; 2007 Jan; 38(1):177-82. PubMed ID: 17122424
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal ultra-low dose naloxone enhances the antinociceptive effect of morphine by enhancing the reuptake of excitatory amino acids from the synaptic cleft in the spinal cord of partial sciatic nerve-transected rats.
Yang CP; Cherng CH; Wu CT; Huang HY; Tao PL; Wong CS
Anesth Analg; 2011 Dec; 113(6):1490-500. PubMed ID: 21865493
[TBL] [Abstract][Full Text] [Related]
36. Involvement of spinal glutamate transporter-1 in the development of mechanical allodynia and hyperalgesia associated with type 2 diabetes.
Shi J; Jiang K; Li Z
J Pain Res; 2016; 9():1121-1129. PubMed ID: 27932896
[TBL] [Abstract][Full Text] [Related]
37. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis.
Dunlop J; Beal McIlvain H; She Y; Howland DS
J Neurosci; 2003 Mar; 23(5):1688-96. PubMed ID: 12629173
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological upregulation of GLT-1 alleviates the cognitive impairments in the animal model of temporal lobe epilepsy.
Ramandi D; Elahdadi Salmani M; Moghimi A; Lashkarbolouki T; Fereidoni M
PLoS One; 2021; 16(1):e0246068. PubMed ID: 33507976
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological enhancement of glutamate transport reduces excitotoxicity in vitro.
Beller JA; Gurkoff GG; Berman RF; Lyeth BG
Restor Neurol Neurosci; 2011; 29(5):331-46. PubMed ID: 21846950
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective potential of ceftriaxone in in vitro models of stroke.
Lipski J; Wan CK; Bai JZ; Pi R; Li D; Donnelly D
Neuroscience; 2007 May; 146(2):617-29. PubMed ID: 17363173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
